Ilex Medical

Importing & marketing medical equipment.

Maya TradingView

Market view

Stock chart

Coverage

Analyses on Ilex Medical (7)

May 27, 2026
May 27, 2026
1. Follow-up
  Starget After the Round: Funding Bought Time, the Going-Concern Warning Still Sets the Pace
  The Series A round and SAFE conversion materially improved Starget's balance sheet and increased the weight of Ilex's holding, but did not remove the central risk. Starget still has no revenue, burns cash, and the going-concern emphasis leaves the thesis dependent on additional…
2. Ilex Medical in the First Quarter: FX Weakens the Core, Cash Funds Starget's Proof Year
  Ilex entered 2026 with a core hurt by currency and diagnostic margin pressure, but not with activity that shrank in its original currency. Cash flow and the balance sheet still buy time, yet that time is now being used for Starget, the dividend and the proton project, so the nex…
April 16, 2026
April 16, 2026
1. The Stronger Shekel In 2025: Who Really Benefits, Who Loses The Benefit, And Who Gets Hurt
  Shekel appreciation in 2025 created a real benefit only for a relatively small part of the market. DELTA BRANDS, URBANICA(PALO), and SUNY COMMUN already show a clear link to gross profit, while a larger group loses part of the benefit to hedging, inventory timing, and competitio…
  +20